Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
- 1 October 2003
- journal article
- Published by Elsevier
- Vol. 39 (4) , 595-605
- https://doi.org/10.1016/s0168-8278(03)00292-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Management of hepatitis B: 2000—Summary of a workshopGastroenterology, 2001
- The liver as a site of T-cell apoptosis: graveyard, or killing field?Immunological Reviews, 2000
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Journal of Clinical Investigation, 1998
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.The Journal of Experimental Medicine, 1995
- T helper cell unresponsiveness: Rapid induction in antigen‐transgenic and reversion in non‐transgenic miceEuropean Journal of Immunology, 1994
- In vitroimmunotoxicity of ±2′-deoxy-3′-thiacytidine, a new and-HIV agentClinical and Experimental Immunology, 1993
- Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.The Journal of Experimental Medicine, 1991
- Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis BJournal of Hepatology, 1991
- Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic MiceScience, 1990